StockWatch
·
Biotechnology
Dividend9 May 2026, 02:31 pm

Advanced Enzyme Tech Recommends ₹1.35 Dividend for FY26

AI Summary

Advanced Enzyme Technologies Ltd's board has recommended a final dividend of 67.5%, which is ₹1.35 per equity share (face value of ₹2 each) for the financial year 2025-26. This is subject to shareholder approval at the upcoming 37th Annual General Meeting (AGM). The dividend, if approved, will be paid starting the second day from the AGM date. The record date and AGM date will be announced later. The board decided to defer the declaration of an interim dividend to preserve capital for strategic opportunities. The board also approved the reappointment of Mr. Mukund Madhusudan Kabra as Whole Time Director for another 5 years and the appointment of Mr. Pradip Bhailal Shah as an Additional Director (Independent) for a term of 5 years, both subject to shareholder approval. Additionally, the reappointment of M S K A & Associates LLP as Statutory Auditors for a second term of five years was approved, also subject to shareholder approval. The board approved the allotment of 49,350 Equity Shares pursuant to the Exercise of Options under Employees Stock Options Scheme 2022.

Key Highlights

  • Advanced Enzyme Tech recommends a final dividend of ₹1.35 per share for FY26.
  • Dividend payout is subject to shareholder approval at the 37th AGM.
  • Board defers interim dividend to preserve capital for strategic avenues.
  • Mukund Kabra re-appointed as Whole Time Director for 5 years.
  • Pradip Bhailal Shah appointed as Additional Director (Independent) for 5 years.